Compounds > arginine vasopressin
Page last updated: 2024-08-18

arginine vasopressin and Heart Defects, Congenital

arginine vasopressin has been researched along with Heart Defects, Congenital in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's1 (10.00)18.2507
2000's3 (30.00)29.6817
2010's5 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Horibata, Y; Kawasoe, Y; Murakami, T; Niwa, K; Tateno, S1
Bigelow, W; Harrell, C; Karki, KB; Krebs, J; Saini, A; Tadphale, SD; Tansey, J; Towbin, JA1
Cassedy, A; Cooper, DS; Flores, S; Iliopoulos, I; Nelson, DP; Pratap, JN1
Agrawal, A; Sharma, R; Singh, VK; Varma, A1
Hara, M; Nagamine, Y1
Hofer, A; Lechner, E; Mair, R; Moosbauer, W; Sames-Dolzer, E; Tulzer, G1
Gortner, L; Gottschling, S; Meyer, S1
Agnoletti, G; Albertini, A; Alfieri, O; Bini, R; Ceconi, C; Curello, S; Ferrari, R; Marzollo, P; Panzali, AF; Scotti, C1
Emmertsen, K; Hansen, OK; Hjortdal, VE; Jensen, KT; Olsen, KH; Pedersen, EB; Ravn, HB; Stenbøg, EV; Sørensen, KE1
Choo, YE; Kim, KT; Lee, JC; Lee, SH; Lee, WJ; Song, WY1

Other Studies

10 other study(ies) available for arginine vasopressin and Heart Defects, Congenital

ArticleYear
Relationship between non-osmotic arginine vasopressin secretion and hemoglobin A1c levels in adult patients with congenital heart disease.
    Heart and vessels, 2019, Volume: 34, Issue:5

    Topics: Adult; Arginine Vasopressin; Biomarkers; Diabetes Mellitus, Type 2; Disease Progression; Female; Glycated Hemoglobin; Heart Defects, Congenital; Heart Failure; Humans; Logistic Models; Male; Middle Aged; Natriuretic Peptide, Brain; Young Adult

2019
Concurrent Use of Calcium Chloride and Arginine Vasopressin Infusions in Pediatric Patients with Acute Cardiocirculatory Failure.
    Pediatric cardiology, 2019, Volume: 40, Issue:5

    Topics: Arginine Vasopressin; Blood Pressure; Calcium Chloride; Cardiac Output; Child, Preschool; Drug Therapy, Combination; Female; Heart Defects, Congenital; Heart Failure; Heart Rate; Humans; Infant; Infant, Newborn; Male; Retrospective Studies; Vasoconstrictor Agents

2019
Arginine-vasopressin therapy in hypotensive neonates and infants after cardiac surgery: response is unrelated to baseline ventricular function.
    Cardiology in the young, 2017, Volume: 27, Issue:6

    Topics: Arginine Vasopressin; Blood Pressure; Cardiac Surgical Procedures; Echocardiography; Female; Follow-Up Studies; Heart Defects, Congenital; Heart Ventricles; Humans; Hypotension; Infant; Infant, Newborn; Male; Retrospective Studies; Time Factors; Treatment Outcome; Vasoconstrictor Agents; Ventricular Dysfunction; Ventricular Function

2017
Intravenous arginine vasopressin infusion in refractory vasodilatory shock: a clinical study.
    Indian journal of pediatrics, 2012, Volume: 79, Issue:4

    Topics: Arginine Vasopressin; Catecholamines; Child; Child, Preschool; Developing Countries; Drug Resistance, Multiple; Female; Heart Defects, Congenital; Hemodynamics; Humans; India; Infant; Infusions, Intravenous; Male; Postoperative Complications; Prospective Studies; Shock; Vasoconstrictor Agents; Vasodilation

2012
[Intravenous arginine vasopressin for two pediatric cases of pulmonary hypertension after congenital heart surgery].
    Masui. The Japanese journal of anesthesiology, 2012, Volume: 61, Issue:10

    Topics: Arginine Vasopressin; Cardiopulmonary Bypass; Female; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; Hypotension; Infant; Infusions, Intravenous; Male; Severity of Illness Index; Treatment Outcome; Vasoconstrictor Agents

2012
Arginine-vasopressin in neonates with vasodilatory shock after cardiopulmonary bypass.
    European journal of pediatrics, 2007, Volume: 166, Issue:12

    Topics: Arginine Vasopressin; Cardiopulmonary Bypass; Female; Heart Defects, Congenital; Humans; Hypotension; Infant, Newborn; Male; Retrospective Studies; Shock, Surgical; Treatment Outcome; Vasoconstrictor Agents; Vasodilation

2007
Arginine-vasopressin as a rescue therapy in children and neonates for catecholamine-resistant shock.
    European journal of pediatrics, 2008, Volume: 167, Issue:3

    Topics: Arginine Vasopressin; Cardiopulmonary Bypass; Child, Preschool; Female; Heart Defects, Congenital; Humans; Hypotension; Infant, Newborn; Male; Shock, Surgical; Treatment Outcome; Vasoconstrictor Agents; Vasodilation

2008
Plasma levels of atrial natriuretic factor (ANF) and urinary excretion of ANF, arginine vasopressin and catecholamines in children with congenital heart disease: effect of cardiac surgery.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 1993, Volume: 7, Issue:10

    Topics: Adolescent; Arginine Vasopressin; Atrial Natriuretic Factor; Catecholamines; Child; Child, Preschool; Female; Heart Defects, Congenital; Hemodynamics; Humans; Infant; Male; Postoperative Period

1993
Neurohormonal activation late after cavopulmonary connection.
    Heart (British Cardiac Society), 2000, Volume: 83, Issue:4

    Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Biomarkers; Child; Child, Preschool; Cross-Sectional Studies; Follow-Up Studies; Heart Bypass, Right; Heart Defects, Congenital; Hemodynamics; Hormones; Humans; Natriuretic Peptide, Brain; Neurosecretory Systems; Postoperative Period; Renin

2000
Responses of vasopressin release in patients with cardiopulmonary bypass anesthetized with enflurane and morphine.
    Journal of Korean medical science, 1989, Volume: 4, Issue:2

    Topics: Adolescent; Adult; Arginine Vasopressin; Blood Pressure; Cardiopulmonary Bypass; Child; Child, Preschool; Enflurane; Heart Defects, Congenital; Humans; Morphine; Osmolar Concentration

1989